BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 2553385)

  • 21. The close relationship between DNA replication and the selection of differentiation lineages of human erythroleukemia cell lines K562, HEL, and TF1 into either erythroid or megakaryocytic lineages.
    Murate T; Saga S; Hotta T; Asano H; Ito T; Kato K; Tsushita K; Kinoshita T; Ichikawa A; Yoshida S
    Exp Cell Res; 1993 Sep; 208(1):35-43. PubMed ID: 8359227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Tumor necrosis factor-alpha expressed constitutively in erythroid cells or induced by erythropoietin has negative and stimulatory roles in normal erythropoiesis and erythroleukemia.
    Jacobs-Helber SM; Roh KH; Bailey D; Dessypris EN; Ryan JJ; Chen J; Wickrema A; Barber DL; Dent P; Sawyer ST
    Blood; 2003 Jan; 101(2):524-31. PubMed ID: 12393629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The biochemistry of erythropoietin: an approach to its mode of action.
    Sytkowski AJ; McIntyre CJ; Perrine SP; Salvado AJ
    Exp Hematol; 1980; 8 Suppl 8():52-64. PubMed ID: 6962071
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The mechanism of action of erythropoietin.
    Spivak JL
    Int J Cell Cloning; 1986 May; 4(3):139-66. PubMed ID: 3009649
    [TBL] [Abstract][Full Text] [Related]  

  • 25. cAMP-induced NF-kappaB (p50/relB) binding to a c-myb intronic enhancer correlates with c-myb up-regulation and inhibition of erythroleukemia cell differentiation.
    Suhasini M; Reddy CD; Reddy EP; DiDonato JA; Pilz RB
    Oncogene; 1997 Oct; 15(15):1859-70. PubMed ID: 9362453
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Maturation of erythroid cells and erythroleukemia development are affected by the kinase activity of Lyn.
    Tilbrook PA; Palmer GA; Bittorf T; McCarthy DJ; Wright MJ; Sarna MK; Linnekin D; Cull VS; Williams JH; Ingley E; Schneider-Mergener J; Krystal G; Klinken SP
    Cancer Res; 2001 Mar; 61(6):2453-8. PubMed ID: 11289114
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Induction of the receptor for erythropoietin in murine erythroleukemia cells after dimethyl sulfoxide treatment.
    Tojo A; Fukamachi H; Saito T; Kasuga M; Urabe A; Takaku F
    Cancer Res; 1988 Apr; 48(7):1818-22. PubMed ID: 2832053
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific binding of erythropoietin to its receptor on responsive mouse erythroleukemia cells.
    Todokoro K; Kanazawa S; Amanuma H; Ikawa Y
    Proc Natl Acad Sci U S A; 1987 Jun; 84(12):4126-30. PubMed ID: 3035570
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fli-1, an Ets-related transcription factor, regulates erythropoietin-induced erythroid proliferation and differentiation: evidence for direct transcriptional repression of the Rb gene during differentiation.
    Tamir A; Howard J; Higgins RR; Li YJ; Berger L; Zacksenhaus E; Reis M; Ben-David Y
    Mol Cell Biol; 1999 Jun; 19(6):4452-64. PubMed ID: 10330185
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of the receptor for erythropoietin on human and murine erythroleukemia cells and modulation by phorbol ester and dimethyl sulfoxide.
    Broudy VC; Lin N; Egrie J; de Haën C; Weiss T; Papayannopoulou T; Adamson JW
    Proc Natl Acad Sci U S A; 1988 Sep; 85(17):6513-7. PubMed ID: 2842774
    [TBL] [Abstract][Full Text] [Related]  

  • 31. AEV-transformed chicken erythroid cells secrete autocrine factors which promote soft agar growth and block erythroleukemia cell differentiation.
    Fasciotto B; Kanazir D; Durkin JP; Whitfield JF; Krsmanovic V
    Biochem Biophys Res Commun; 1987 Mar; 143(2):775-81. PubMed ID: 3471218
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An activating mutation in the kit receptor abolishes the stroma requirement for growth of ELM erythroleukemia cells, but does not prevent their differentiation in response to erythropoietin.
    Leslie NR; O'Prey J; Bartholomew C; Harrison PR
    Blood; 1998 Dec; 92(12):4798-807. PubMed ID: 9845547
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Alternative splicing of the erythropoietin receptor gene correlates with erythroid differentiation in rat hematopoietic and leukemic cells.
    Fujita M; Takahashi R; Kitada K; Watanabe R; Kitazawa S; Ashoori F; Liang P; Saya H; Serikawa T; Maeda S
    Cancer Lett; 1997 Jan; 112(1):47-55. PubMed ID: 9029168
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Potentiation of the erythropoietin response by dimethyl sulfoxide priming of erythroleukemia cells: evidence for interaction of two signaling pathways.
    Chern Y; Yonekura S; Sytkowski AJ
    Blood; 1990 Dec; 76(11):2204-9. PubMed ID: 2175220
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A rapid fatal erythroleukemia caused by J2E cells can be treated ex vivo with erythropoietin.
    Farr TJ; Lai CM; Beilharz MW; Papadimitriou J; Riches K; Rossi E; Garcia-Webb P; Klinken SP
    Leukemia; 1995 May; 9(5):900-7. PubMed ID: 7769854
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Erythropoietin rapidly reduces phosphorylation of a membrane protein in a murine erythroleukemia cell line.
    Sawada T; Tsuda H; Mori KJ; Kawakita M; Takatsuki K
    Int J Hematol; 1991 Apr; 54(2):109-15. PubMed ID: 1836139
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of the erythropoietin receptor on a Friend murine erythroleukemic cell clone, TSA8.
    Kitamura T; Tojo A; Fukamachi H; Akahane K; Saito T; Urabe A; Takaku F
    Nihon Ketsueki Gakkai Zasshi; 1988 Jul; 51(4):677-85. PubMed ID: 2849278
    [No Abstract]   [Full Text] [Related]  

  • 38. Oncogene cooperativity in Friend erythroleukemia: erythropoietin receptor activation by the env gene of SFFV leads to transcriptional upregulation of PU.1, independent of SFFV proviral insertion.
    Afrikanova I; Yeh E; Bartos D; Watowich SS; Longmore GD
    Oncogene; 2002 Feb; 21(8):1272-84. PubMed ID: 11850847
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Induction of erythroid differentiation by inhibition of Ras/ERK pathway in a friend murine leukemia cell line.
    Matsuzaki T; Aisaki Ki; Yamamura Y; Noda M; Ikawa Y
    Oncogene; 2000 Mar; 19(12):1500-8. PubMed ID: 10734309
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Spi-1/PU.1 participates in erythroleukemogenesis by inhibiting apoptosis in cooperation with Epo signaling and by blocking erythroid differentiation.
    Rimmelé P; Kosmider O; Mayeux P; Moreau-Gachelin F; Guillouf C
    Blood; 2007 Apr; 109(7):3007-14. PubMed ID: 17132716
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.